Pradžia › Anemija › Pennsylvania
Anemija klinikiniai tyrimai Pennsylvania
7 tyrimai dėl Anemija ieško dalyvių vietose Pennsylvania.
Miestai Pennsylvania
Oficialus tyrimo tekstas (anglų kalba)
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Thomas Jefferson University, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- Allegheny Health Network Cancer Institute - West Penn Hospital Location, Pittsburgh
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07623161Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- University of Pennsylvania, Philadelphia
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT05320198A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT07422480T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Renkami dalyviai1/2 fazė
Amžius nuo 5 iki 40 · Visoms lytims · Atnaujinta 2026-08-13 · NCT03653338Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
- Childrens Hospital of Philadelphia, Philadelphia
Renkami dalyviai3 fazė
Amžius nuo 2 iki 18 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06934967Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
- Fox Chase Cancer Center, Philadelphia
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-22 · NCT05800600Oral Iron in Children With Chronic Kidney Disease
- Children's Hospital of Philadelphia, Philadelphia
Renkami dalyviai4 fazė
Amžius nuo 1 iki 21 · Visoms lytims · Atnaujinta 2025-08-11 · NCT03991169Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.